Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Insulet Corporation (PODD) trades at a EV/EBITDA of 16.6×. Over the past ten years it has ranged from 0.0× (December 2016) to 1,357× (November 2017); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 35.9× (25.37%)
FY2024 48.0× (8.02%)
FY2023 52.2× (74.44%)
FY2022 204× 102.60%
FY2021 101× (35.29%)
FY2020 156× 11.49%
FY2019 140× 20.32%
FY2018 116× (81.81%)
FY2017 639× (9.00%)
FY2016 702× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 17.8× (29.18%)
Mar 2026 25.2× (29.79%)
Dec 2025 35.9× (14.45%)
Sep 2025 41.9× (7.51%)
42 more quarters

Against its own ten years

Low 0.0× High 1,357×
Ten-year median 122×
Current reading's percentile 16

EV/EBITDA against peers

Company EV/EBITDA
GKOS Glaukos Corporation compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.0×
GMED Globus Medical, Inc. compare 11.4×
PODD Insulet Corporation 16.6×
HAE Haemonetics Corporation compare 23.1×
BRKR Bruker Corporation compare 50.1×
PEN Penumbra, Inc. compare 58.6×
BIO Bio-Rad Laboratories, Inc. compare 170×
BIO.B Bio-Rad Laboratories, Inc. compare 176×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PODD